Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008466:Mechlorethamine; D008558:Melphalan; D008698:Mesylates; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010649:Phenylalanine
D000970:Antineoplastic Agents; D008698:Mesylates; D009588:Nitrogen Mustard Compounds; C045880:methanesulfonic acid; D010649:Phenylalanine; D008466:Mechlorethamine; C097006:2-chloroethyl methanesulfonate; D008558:Melphalan
CYTOTOXIC DRUGS/therapeutic use; NITROGEN MUSTARDS/therapeutic use